Pioneering the Fight Against Antimicrobial Resistance
At TAXIS Pharmaceuticals, our mission is clear: to combat antimicrobial resistance and save lives.
The Time to Act is Now
Antimicrobial resistance demands immediate, coordinated action from governments, healthcare providers, researchers, and the pharmaceutical industry. By investing in innovative solutions and fostering global collaboration, we can save lives.
Who We Are
TAXIS Pharmaceuticals is a privately held biopharmaceutical company dedicated to eliminating the threat of current and emergent antimicrobial resistance across a wide range of infectious diseases. We are currently researching new classes of anti-resistance agents that employ novel mechanisms of action.
We are focusing our science on the disruption of the foundation of bacterial cell wall architecture — including construction, maintenance, and growth — to address elemental drug resistance mechanisms.
TAXIS was founded in 2009. Our corporate headquarters is in Monmouth Junction, NJ.
